Zobrazeno 1 - 10
of 58
pro vyhledávání: '"Ari Grinspan"'
Autor:
Emily Tixier, Yuying Luo, Ryan C. Ungaro, Elijah Verheyen, Ari Grinspan, Samantha Walsh, Lauren Tal Grinspan, Charles Du
Publikováno v:
Digestive Diseases and Sciences. 67:978-988
Severe and fulminant Clostridioides difficile infection (CDI) is associated with significant morbidity and mortality. While fecal microbiota transplantation (FMT) has proved to be a highly effective treatment for recurrent CDI, its efficacy in severe
Autor:
Prameela Rao, Jenny S. Sauk, Laurie Keefer, Robert Hirten, Bruce E. Sands, Lin Chang, Matteo Danieletto, Zachary A. Borman, Erwin Bӧttinger, Bert Arnrich, Stephanie Stanley, Ari Grinspan
Publikováno v:
Digestive Diseases and Sciences. 66:1836-1844
Wearable devices are designed to capture health-related and physiological data. They may be able to improve inflammatory bowel disease management and address evolving research needs. Little is known about patient perceptions for their use in the stud
Autor:
Sergey Khaitov, Anam Rizvi, Ari Grinspan, Marla Dubinsky, Emily Tixier, Alexa Riggs, Patricia Sylla, Maia Kayal, Michael Plietz, Marlana Radcliffe, Alexander Greenstein, Parth D. Trivedi
Publikováno v:
Inflammatory Intestinal Diseases. 5:59-64
Introduction: The true incidence of Clostridioides difficile infection (CDI) in patients with an ileal pouch is unknown, and there is little published on its associated risk factors. Objective: We aimed to evaluate the rate and risk factors of CDI in
Publikováno v:
Digestive Diseases and Sciences. 65:1125-1133
Recurrent Clostridioides difficile infections (CDIs) occur frequently and pose a substantial economic burden on the US healthcare system. The landscape for the treatment of CDI is evolving. To elucidate the most cost-effective strategy for managing r
Autor:
Colleen R. Kelly, Benjamin H. Mullish, Ari Grinspan, Monika Fischer, Jessica R. Allegretti, Zain Kassam
Publikováno v:
Gastroenterology. 159:1982-1984
There has been an increase in the burden of Clostridioides difficile infection (CDI),1 especially in high-risk populations such as patients with inflammatory bowel disease (IBD).2 The prevalence of CDI in the IBD population is up to 8-fold higher tha
Publikováno v:
Therapeutic Advances in Gastroenterology
Clostridioides difficile infection is a leading cause of healthcare-associated infections with significant morbidity and mortality. For the past decade, the bulk of infection prevention and epidemiologic surveillance efforts have been directed toward
Publikováno v:
Journal of Pediatric Gastroenterology & Nutrition. 68:343-347
Recurrent Clostridium difficile infection (RCDI) increases morbidity and mortality in patients with inflammatory bowel disease (IBD). Fecal microbiota transplant (FMT) is known to be very effective for RCDI in non-IBD patients with cure rates up to 9
Autor:
Casey D. Morrow, Lawrence J. Brandt, Monika Fischer, Zain Kassam, Martin A. Rodriguez, Sonia Timberlake, Olga C. Aroniadis, Marina Santiago, Jessica R. Allegretti, Lindsay Eysenbach, Mark Smith, Ari Grinspan, Colleen R. Kelly, Majdi Osman
Publikováno v:
AIMS Microbiology. 5:1-18
The gastrointestinal microbiome is intrinsically linked to the spread of antibiotic resistance. Antibiotic treatment puts patients at risk for colonization by opportunistic pathogens like vancomycin resistant Enterococcus and Clostridioides difficile
Autor:
Thomas J. Louie, Richard Nathan, Ian Davis, John Pullman, Shrish Budree, Zain Kassam, Sahil Khanna, Thomas J. Borody, Sarah K. McGill, Robert Orenstein, Najwa El-Nachef, Jeff S. Bullock, Colleen R. Kelly, Michael Silverman, Facg, Ari Grinspan, Jessica R. Allegretti, Monika Fisher, Nicholas W. Van Hise, Darrell S. Pardi, Eugene F. Yen, Susy Hota, Colleen S. Kraft, Misra Bg
Publikováno v:
American Journal of Gastroenterology. 116:S63-S64
Publikováno v:
Journal of clinical gastroenterology. 55(4)
GOALS We performed a systematic review with meta-analysis to examine the efficacy and safety of oral fecal microbiota transplantation (FMT) capsules for recurrent Clostridioides difficile infection (rCDI). BACKGROUND FMT through colonoscopy is establ